Research Article

The effect of prophylactic vitamin C use on COVID-19 infection

Volume: 5 Number: 1 January 17, 2022
EN

The effect of prophylactic vitamin C use on COVID-19 infection

Abstract

Aim: In vitamin C deficiency, the immune system deteriorates and the body becomes more susceptible to infections. Since vitamin C levels will decrease significantly in infectious conditions due to increased metabolic requirements, the daily need for vitamin C increases. In our study, it was aimed to investigate the effects of 500 mg and more vitamin C intake on COVID-19 infection during the pandemic process. Material and Method: A group consisting of 100 participants who received vitamin C supplements at a daily dose of at least 500 mg daily for a minimum of 1-3 months in their diet and a control group of 100 people who did not receive vitamin supplements were included in the study. While determining the amount of Vitamin C intake of the participants; The amount of Vitamin C in oral food supplements or foods containing vitamin C in their diets (orange, tangerine, grapefruit, kiwi, pineapple, strawberry, lemon, red and green peppers, tomatoes, arugula, parsley, greens such as lettuce, fresh rosehip, broccoli, cabbage, spinach) The vitamin level was calculated according to the amount of vegetables (such as vegetables). None of the participants had side effects suggestive of vitamin C toxicity. Besides the height, weight, gender, age, known illness and other demographic data of all participants; COVID-19 disease status, contact with COVID-19 patients, and whether or not they had a COVID infection after contact were examined. In addition, data on the presence of symptoms, severity and duration of the disease were noted in patients with COVID-19 infection, and both groups were compared statistically in terms of results. Results: In the group receiving less than 500 mg daily; COVID-19 infection symptoms, respiratory distress, disease severity were found to be higher, and the symptoms were found to be more aggressive. While total contact and high-risk contact at all levels was higher in the group that received more than 500 mg of vitamin C daily, the rate of being COVID was lower compared to the other groups. Conclusion: One of the most effective precautions to be taken to increase body resistance against COVID-19 is adequate vitamin C intake. In the study, it has been shown that adequate vitamin C taken with both food and nutritional supplements reduce the risk of getting COVID-19, reduce the risk of severe respiratory distress on COVID-19, as well as reduce both symptoms and symptom duration.

Keywords

References

  1. Drouin G, JR Godin, B Pagé, The genetics of vitamin C loss in vertebrates. Curr Genomics 2011; 12: 371-8.
  2. Carr AC, Maggini S. Vitamin C and immune function. Nutrients 2017; 9: 1211.
  3. Maggini S, Wintergerst ES, Beveridge S, Hornig DH. Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses. Br J Nutr 2007; 98: 29-35.
  4. German Nutrition Society (DGE). New reference values for vitamin C intake. Ann Nutr Metab 2015; 67: 13-20.
  5. Holford P, Carr AC, Jovic TH, et al. Vitamin C-an adjunctive therapy for respiratory infection, sepsis and COVID-19. Nutrients 2020; 12: 3760.
  6. Naserghandi A, Allameh SF, Saffarpour R. All about COVID-19 in brief. New Microbes New Infect 2020; 35: 100678.
  7. Hemilä H. Vitamin C and infections. Nutrients 2017; 9: 339.
  8. Hume R, Weyers E. Changes in leucocyte ascorbic acid during the common cold. Scott Med J 1973; 18: 3-7.

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Research Article

Publication Date

January 17, 2022

Submission Date

June 4, 2021

Acceptance Date

October 6, 2021

Published in Issue

Year 2022 Volume: 5 Number: 1

APA
Kızılkaya, H., & Gençer, V. (2022). The effect of prophylactic vitamin C use on COVID-19 infection. Journal of Health Sciences and Medicine, 5(1), 13-17. https://doi.org/10.32322/jhsm.948014
AMA
1.Kızılkaya H, Gençer V. The effect of prophylactic vitamin C use on COVID-19 infection. J Health Sci Med / JHSM. 2022;5(1):13-17. doi:10.32322/jhsm.948014
Chicago
Kızılkaya, Hafize, and Vedat Gençer. 2022. “The Effect of Prophylactic Vitamin C Use on COVID-19 Infection”. Journal of Health Sciences and Medicine 5 (1): 13-17. https://doi.org/10.32322/jhsm.948014.
EndNote
Kızılkaya H, Gençer V (January 1, 2022) The effect of prophylactic vitamin C use on COVID-19 infection. Journal of Health Sciences and Medicine 5 1 13–17.
IEEE
[1]H. Kızılkaya and V. Gençer, “The effect of prophylactic vitamin C use on COVID-19 infection”, J Health Sci Med / JHSM, vol. 5, no. 1, pp. 13–17, Jan. 2022, doi: 10.32322/jhsm.948014.
ISNAD
Kızılkaya, Hafize - Gençer, Vedat. “The Effect of Prophylactic Vitamin C Use on COVID-19 Infection”. Journal of Health Sciences and Medicine 5/1 (January 1, 2022): 13-17. https://doi.org/10.32322/jhsm.948014.
JAMA
1.Kızılkaya H, Gençer V. The effect of prophylactic vitamin C use on COVID-19 infection. J Health Sci Med / JHSM. 2022;5:13–17.
MLA
Kızılkaya, Hafize, and Vedat Gençer. “The Effect of Prophylactic Vitamin C Use on COVID-19 Infection”. Journal of Health Sciences and Medicine, vol. 5, no. 1, Jan. 2022, pp. 13-17, doi:10.32322/jhsm.948014.
Vancouver
1.Hafize Kızılkaya, Vedat Gençer. The effect of prophylactic vitamin C use on COVID-19 infection. J Health Sci Med / JHSM. 2022 Jan. 1;5(1):13-7. doi:10.32322/jhsm.948014

Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].

The Directories (indexes) and Platforms we are included in are at the bottom of the page.

Note: Our journal is not WOS indexed and therefore is not classified as Q.

You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show







The indexes of the journal are ULAKBİM TR Dizin, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.

       images?q=tbn:ANd9GcRB9r6zRLDl0Pz7om2DQkiTQXqDtuq64Eb1Qg&usqp=CAU

500px-WorldCat_logo.svg.png

atifdizini.png

logo_world_of_journals_no_margin.png

images?q=tbn%3AANd9GcTNpvUjQ4Ffc6uQBqMQrqYMR53c7bRqD9rohCINkko0Y1a_hPSn&usqp=CAU

doaj.png  

images?q=tbn:ANd9GcSpOQFsFv3RdX0lIQJC3SwkFIA-CceHin_ujli_JrqBy3A32A_Tx_oMoIZn96EcrpLwTQg&usqp=CAU

ici2.png

asos-index.png

drji.png





The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.

COPE-logo-300x199.jpgimages?q=tbn:ANd9GcQR6_qdgvxMP9owgnYzJ1M6CS_XzR_d7orTjA&usqp=CAU

icmje_1_orig.png

cc.logo.large.png

ncbi.pngimages?q=tbn:ANd9GcRBcJw8ia8S9TI4Fun5vj3HPzEcEKIvF_jtnw&usqp=CAU

ORCID_logo.png

1*mvsP194Golg0Dmo2rjJ-oQ.jpeg


Our Journal using the DergiPark system indexed are;

Ulakbim TR Dizin,  Index Copernicus, ICI World of JournalsDirectory of Research Journals Indexing (DRJI), General Impact FactorASOS Index, OpenAIRE, MIAR,  EuroPub, WorldCat (OCLC)DOAJ,  Türkiye Citation Index, Türk Medline Index, InfoBase Index


Our Journal using the DergiPark system platforms are;

Google, Google Scholar, CrossRef (DOI), ResearchBib, ICJME, COPE, NCBI, ORCID, Creative Commons, Open Access, and etc.


Journal articles are evaluated as "Double-Blind Peer Review". 

Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user.  https//dergipark.org.tr/tr/pub/jhsm/page/9535

Journal charge policy   https://dergipark.org.tr/tr/pub/jhsm/page/10912

Our journal has been indexed in DOAJ as of May 18, 2020.

Our journal has been indexed in TR-Dizin as of March 12, 2021.


17873

Articles published in Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.